Trials / Sponsors / Tianjin Institute of Pharmaceutical Research Co., Ltd
Tianjin Institute of Pharmaceutical Research Co., Ltd
Other Government · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE). Ischemic Stroke | Phase 2 | 2025-02-21 |
| Completed | Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects Acute Coronary Syndrome, Ischemic Stroke | Phase 1 | 2024-09-09 |